Surmodics Inc. (SRDX)
NASDAQ: SRDX
· Real-Time Price · USD
32.38
-1.01 (-3.02%)
At close: Sep 05, 2025, 3:59 PM
32.36
-0.06%
After-hours: Sep 05, 2025, 07:56 PM EDT
Surmodics Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 16.76M | 14.99M | 16.55M | 19.1M | 17.56M | 18.1M | 18.83M | 15.36M | 34.15M | 15.35M | 14.23M | 14.39M | 13.92M | 13.96M | 12.34M | 12.51M | 12.08M | 11.78M | 10.1M | 10.59M | 11.99M | 11.77M | 9.97M | 10.71M | 9.87M | 9.93M | 10.1M | 10.32M | 9.6M |
| Product Revenue Growth | +11.79% | -9.40% | -13.37% | +8.77% | -2.97% | -3.87% | +22.55% | -55.02% | +122.50% | +7.84% | -1.11% | +3.41% | -0.32% | +13.12% | -1.32% | +3.52% | +2.55% | +16.64% | -4.57% | -11.69% | +1.84% | +18.01% | -6.88% | +8.52% | -0.62% | -1.62% | -2.20% | +7.56% | n/a |
| Research Development And Other Revenue | 3.15M | 3.19M | 2.74M | 2.69M | 2.32M | 2.45M | 2.55M | 2.56M | 15.67M | 2.42M | 1.93M | 2.08M | 2.14M | 2.3M | 2.56M | 2.59M | 2.99M | 3.16M | 2.86M | 2.09M | 2.5M | 2.83M | 2.49M | 3.3M | 2.85M | 9.89M | 9.75M | 10.7M | 10.47M |
| Research Development And Other Revenue Growth | -1.13% | +16.24% | +2.05% | +15.68% | -5.19% | -3.85% | -0.39% | -83.69% | +547.66% | +25.08% | -7.20% | -2.62% | -6.88% | -10.23% | -1.08% | -13.53% | -5.28% | +10.45% | +36.89% | -16.33% | -11.76% | +13.51% | -24.40% | +15.75% | -71.17% | +1.39% | -8.90% | +2.19% | n/a |
| Royalty Revenue | 9.66M | 9.91M | 10.63M | n/a | 10.46M | 11.41M | 9.18M | 10.05M | 2.66M | 9.43M | 8.77M | 9.51M | 8.79M | 9.84M | 8.1M | 8.87M | 8.8M | 20.05M | 9.33M | 9.87M | 12.4M | 8.22M | 10.15M | 16.81M | 11.62M | n/a | n/a | n/a | n/a |
| Royalty Revenue Growth | -2.52% | -6.84% | n/a | n/a | -8.35% | +24.32% | -8.68% | +277.43% | -71.76% | +7.58% | -7.83% | +8.13% | -10.66% | +21.55% | -8.73% | +0.89% | -56.13% | +114.83% | -5.40% | -20.41% | +50.81% | -18.99% | -39.62% | +44.58% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.75M | 15.04M | 15.17M | 14.58M | 16.63M | 13.09M | 12.54M | 12.81M | 12.87M | 12.97M | 13.24M | 13.78M | 12.85M | 11.11M | 9.19M | 7.87M | 7.88M | 7.91M | 7.02M | 7.3M | 7.42M | 6.73M | 6.94M | 7.19M | 5.94M | 4.88M | 5.95M | 6.5M | 5.98M | 6.44M | 5.19M | 5.31M | 5.23M | 5.08M | 4.86M | 5.01M | 4.48M | 4.85M | 3.61M | 6.18M | 4.02M | 4.13M |
| Selling, General, and Administrative Revenue Growth | +17.98% | -0.85% | +4.08% | -12.32% | +26.99% | +4.43% | -2.11% | -0.52% | -0.74% | -2.03% | -3.92% | +7.20% | +15.67% | +20.90% | +16.87% | -0.25% | -0.28% | +12.59% | -3.79% | -1.56% | +10.14% | -3.02% | -3.38% | +21.00% | +21.80% | -18.04% | -8.55% | +8.83% | -7.19% | +24.13% | -2.24% | +1.43% | +3.07% | +4.40% | -2.97% | +11.78% | -7.62% | +34.51% | -41.66% | +53.72% | -2.47% | n/a |
| Research and Development Revenue | 3.15M | 3.19M | 2.74M | 2.69M | 9.77M | 10.23M | 8.66M | 9.7M | 2.66M | 2.42M | 1.93M | 2.08M | 2.14M | 2.3M | 2.56M | 2.86M | 2.99M | 3.16M | 2.86M | 12.79M | 13.32M | 11.94M | 12.14M | 14.52M | 13.32M | 13.55M | 11.49M | 12.59M | 9.78M | 10.77M | 7.83M | 9.71M | 7.93M | 8.21M | 5.97M | 5.3M | 4.69M | 4.87M | 3.63M | 4.33M | 3.86M | 4.4M |
| Research and Development Revenue Growth | -1.13% | +16.24% | +2.05% | -72.50% | -4.54% | +18.06% | -10.64% | +264.10% | +10.09% | +25.08% | -7.20% | -2.62% | -6.88% | -10.23% | -10.52% | -4.41% | -5.28% | +10.45% | -77.63% | -4.03% | +11.64% | -1.70% | -16.39% | +9.02% | -1.73% | +18.01% | -8.78% | +28.77% | -9.24% | +37.58% | -19.38% | +22.53% | -3.42% | +37.49% | +12.58% | +13.00% | -3.59% | +33.96% | -16.00% | +12.07% | -12.33% | n/a |